Avel eCare, a provider of clinician-to-clinician telemedicine services, announced the acquisition of NightWatch, a provider of remote pharmacy services to hospitals, clinics, and nursing homes throughout the Midwest and mid-Atlantic region.
The terms of the acquisition were not disclosed.
The acquisition strengthens our existing suite of telemedicine offerings and enables us to expand our reach to better serve customers across the United States, Avel eCare said in a press statement.
Commenting on the acquisition, Doug Duskin, CEO of Avel eCare, said, “Avel continues to experience a high level of demand for its telemedicine services and believes that the trend will continue as the market leverages telemedicine services to meet patient and health system needs. An important aspect of our acute telemedicine services resides with our unique pharmacy services.”
“This combination of two companies will expand our operations and ability to support customers across new states and geographies, which in turn will prevent additional strains on the healthcare system,” added Doug Duskin.
Christopher Vaught, the owner of Vaught Inc, the parent company of NightWatch, said, “Since founding in 2008, NightWatch has been providing after-hours remote hospital pharmacy coverage to help ensure patient safety and prevent burnout among pharmacists. Joining Avel eCare and its expansive network of resources will allow our pharmacists to better meet the growing needs of customers and the communities they serve.”
M&A activity
More than 3000+ digital health technology companies have been acquired to date, according to our M&A database. The latest acquisitions in pharmacy software services include:
SpendMend, a provider of tech-enabled solutions to optimize the cost cycle for the healthcare industry, acquired Trulla, a provider of pharmacy sourcing, supply chain, and procurement software solutions.
BD (Becton, Dickinson and Company), a medical technology company, acquired MedKeeper, a provider of cloud-based pharmacy operations management applications, to expand its portfolio of connected medication management capabilities.
